1 Bundesamt für Gesundheit BAG. HIV, Syphilis, Gonorrhoe und Chlamydiose in der Schweiz im Jahr 2015: eine epidemiologische Übersicht. BAG Bulletin. 2016;12–3.
2 Testing for Chlamydia trachomatis: time trends in positivity rates in the canton of Basel-Stadt, Switzerland. Epidemiology and Infection. 2012;141:1953.
3 Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M. 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2015;27:333–48.
4 Bally F, Quach A, Greub G, et al. Opportunistic testing for urogenital infection with Chlamydia trachomatis in south-western Switzerland, 2012: a feasibility study. Euro Surveill. 2015;20:21051.
5 Price MJ, Ades AE, Soldan K, et al. The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. Health Technol Assess. 2016;20:1–250.
6 Rekart ML, Gilbert M, Meza R, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis. 2012;207:30–8.
7 Moore MS, Golden MR, Scholes D, Kerani RP. Assessing Trends in Chlamydia Positivity and Gonorrhea Incidence and Their Associations With the Incidence of Pelvic Inflammatory Disease and Ectopic Pregnancy in Washington State, 1988–2010.
Sex Transm Dis. 2015;43:2–8.
8 Papp JR, Schachter J, Gaydos CA, Van Der Pol B. Recommendations for the Laboratory-Based Detection of Chlamydia trachomatis and Neisseria gonorrhoeae – 2014. MMWR – Recommendations and Reports. 2014;63:1–19.
9 Berry L, Stanley B. Comparison of self-collected meatal swabs with urine specimens for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men. J Med Microbiol. 2017;66:134–6.
10 Dize L, Barnes P, Barnes M, et al. Performance of self-collected penile-meatal swabs compared to clinician-collected urethral swabs for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium by nucleic acid amplification assays. Diagn Microbiol Infect Dis. 2016;86:131–5.
11 Dize L, Agreda P, Quinn N, Barnes MR, Hsieh Y-H, Gaydos CA. Comparison of self-obtained penile-meatal swabs to urine for
the detection of C. trachomatis, N. gonorrhoeae and T. vaginalis.
Sex Transm Infect. 2012;89:305–7.
12 Nwokolo NC, Dragovic B, Patel S, Tong CYW, Barker G, Radcliffe K. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2015;27:251–67.
13 Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;340:c1642.
14 Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1–137.
15 Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection.
N Engl J Med. 2015;373:2512–21.
16 Bremer V, Brockmeyer NH, Frobenius W, et al. S2k-Leitlinie: Infektionen mit Chlamydia trachomatis. AWMF online 2016;
17 Toutous Trellu L, Oertle D, Itin P, Furrer H, Scheidegger C, Stoeckle M, et al. Gonorrhoe: neue Empfehlungen zu Diagnostik und Behandlung. Swiss Med Forum. 2014; 14(20):407–9.
18 Heijne JCM, van Liere GAFS, Hoebe CJPA, Bogaards JA, van Benthem BHB, Dukers-Muijrers NHTM. What explains anorectal chlamydia infection in women? Implications of a mathematical model for test and treatment strategies. Sex Transm Infect. 2016;sextrans–2016–052786.
19 Rank RG, Yeruva L. Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection. Infect Immun. 2014; 82:1362–71.
21 Kälin U, Lauper U, Lautenschlager S. Urethritis. Erregerspektrum, Abklärung und Therapie
Teil 1. Swiss Med Forum. 2009;09(05):
101–4.
22 Kälin U, Lauper U, Lautenschlager S. Urethritis. Erregerspektrum, Abklärung und Therapie
Teil 2. Swiss Med Forum. 2009;09(06):
121–4.